HCA Healthcare, Inc.
corporate_fare Company Profile
HCA Healthcare, Inc. (NYSE:HCA) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 25 items for HCA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for HCA spans 10-Q, 8-K, DEF 14A.
Recent high-impact activity:
- HCA Healthcare Completes Acquisition of The College of Health Care Professions
- HCA Q2 Revenue Tops $20.2B, but Uncompensated Care Surges and Cash Flow Drops
- HCA Narrows Revenue View to $77B-$79.5B, Trims EPS Outlook
- HCA Q2 Profit Rises to $1.7B, Revenue Hits $20.2B; Full-Year Revenue Guidance Set at $77B-$79.5B
- HCA Healthcare Delivers Q2 2026 Results, Declares Dividend, and Updates Guidance
Financial Snapshot
Short Interest & Short Volume
4.52 days to coverFINRA reported short interest of 6,479,985 shares in HCA as of the September 15, 2026 settlement, a 5.6% increase from the prior period — about 4.5 days to cover at its recent average daily volume. On October 2, 2026, 70.5% of HCA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for HCA, detected from its recent SEC filings · based on capital-structure filings through 2026-04-27.
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →